IL58076A - Spiro-oxazolidine diones and pharmaceutical compositions containing them - Google Patents

Spiro-oxazolidine diones and pharmaceutical compositions containing them

Info

Publication number
IL58076A
IL58076A IL58076A IL5807679A IL58076A IL 58076 A IL58076 A IL 58076A IL 58076 A IL58076 A IL 58076A IL 5807679 A IL5807679 A IL 5807679A IL 58076 A IL58076 A IL 58076A
Authority
IL
Israel
Prior art keywords
spiro
pharmaceutical compositions
compositions containing
diones
oxazolidine
Prior art date
Application number
IL58076A
Other languages
English (en)
Other versions
IL58076A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL58076A0 publication Critical patent/IL58076A0/xx
Publication of IL58076A publication Critical patent/IL58076A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06Benzothiopyrans; Hydrogenated benzothiopyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Moulding By Coating Moulds (AREA)
  • Dental Preparations (AREA)
  • Photosensitive Polymer And Photoresist Processing (AREA)
IL58076A 1978-08-21 1979-08-20 Spiro-oxazolidine diones and pharmaceutical compositions containing them IL58076A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/935,199 US4200642A (en) 1978-08-21 1978-08-21 Spiro-oxazolidindiones

Publications (2)

Publication Number Publication Date
IL58076A0 IL58076A0 (en) 1979-12-30
IL58076A true IL58076A (en) 1982-07-30

Family

ID=25466700

Family Applications (1)

Application Number Title Priority Date Filing Date
IL58076A IL58076A (en) 1978-08-21 1979-08-20 Spiro-oxazolidine diones and pharmaceutical compositions containing them

Country Status (34)

Country Link
US (1) US4200642A (fr)
JP (4) JPS6011914B2 (fr)
AR (1) AR225614A1 (fr)
AT (1) AT366689B (fr)
AU (1) AU535170B2 (fr)
BE (1) BE878311A (fr)
CA (1) CA1121361A (fr)
CH (1) CH639974A5 (fr)
CS (1) CS208129B2 (fr)
DD (1) DD146602A5 (fr)
DE (2) DE2953954C2 (fr)
DK (1) DK258479A (fr)
EG (1) EG14639A (fr)
ES (1) ES483511A1 (fr)
FI (1) FI65255C (fr)
FR (3) FR2442851A1 (fr)
GB (2) GB2028318B (fr)
GR (1) GR71913B (fr)
HU (1) HU179746B (fr)
IE (1) IE48932B1 (fr)
IL (1) IL58076A (fr)
IN (1) IN152416B (fr)
IT (1) IT1123536B (fr)
LU (1) LU81613A1 (fr)
NL (1) NL7906318A (fr)
NO (1) NO792699L (fr)
NZ (1) NZ191350A (fr)
PH (1) PH18091A (fr)
PL (1) PL130686B1 (fr)
PT (1) PT70086A (fr)
SE (1) SE447116B (fr)
SU (1) SU942597A3 (fr)
YU (1) YU41488B (fr)
ZA (1) ZA794379B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4329459A (en) * 1980-05-05 1982-05-11 The Upjohn Company Tetrahydrobenzopyran derivatives
SG56656G (en) * 1980-07-28 1987-03-27 Pfizer Hypoglycemic 5-substituted oxazolidine-2, 4-diones
US4367234A (en) * 1980-07-28 1983-01-04 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones
ES515751A0 (es) * 1981-10-13 1983-10-16 Pfizer "un procedimiento por analogia para la preparacion de derivados de espiro-oxindol-oxazolidindiona".
US4438272A (en) 1982-04-15 1984-03-20 Alcon Laboratories, Inc. Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones
US4540700A (en) * 1982-04-15 1985-09-10 Alcon Laboratories, Inc. Treatment of diabetic complications with certain spiro-imidazolidine-diones
US4436745A (en) 1982-04-15 1984-03-13 Alcon Laboratories, Inc. Method of inhibiting aldose reductase activity
US4464385A (en) * 1982-04-15 1984-08-07 Alcon Laboratories, Inc. Treatment of diabetic complications with hydantoins
ZA832679B (en) * 1982-05-07 1983-12-28 Ici Plc Indoline derivatives
US4430337A (en) * 1982-06-23 1984-02-07 Pfizer Inc. Alicyclic substituted oxazolidine-2,4-diones having hypoglycemic activity
US4556670A (en) * 1982-12-06 1985-12-03 Pfizer Inc. Spiro-3-hetero-azolones for treatment of diabetic complications
US4464380A (en) * 1983-05-25 1984-08-07 Pfizer Inc. Imidazolidinedione derivatives
US4533667A (en) * 1983-05-25 1985-08-06 Pfizer Inc. Imidazolidinedione derivatives
DK277484A (da) * 1983-06-23 1984-12-24 Hoffmann La Roche Thiazolidinderivater
JPS61200991A (ja) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk スピロ―3―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤
DE3522791C1 (en) * 1985-06-26 1987-01-02 Ferroplast Gmbh Positioning wall for lagging a cavity to be filled with a hardenable material in mining or tunnelling
WO1987004344A1 (fr) * 1986-01-17 1987-07-30 Pfizer Inc. Derives de l'acide hydroxyacetique pour le traitement de complications diabetiques
US5039672A (en) * 1990-04-05 1991-08-13 Pfizer Inc. Heterocyclic compounds as aldose reductase inhibitors
US5068332A (en) * 1990-10-12 1991-11-26 American Home Products Corporation Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones useful as aldose reductase inhibitors
US5102886A (en) * 1990-10-12 1992-04-07 American Home Products Corporation 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones and analogs thereof useful as aldose reductase inhibitors
FR2707981B1 (fr) * 1993-07-20 1995-09-01 Adir Nouveaux dérivés de benzospiroalcène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
EP1194146B1 (fr) 1999-06-18 2006-07-19 Merck & Co., Inc. Derives d'arylthiazolidinedione et d'aryloxazolidinedione
EP1194147B1 (fr) 1999-06-18 2007-01-10 Merck & Co., Inc. Derives d'arylthiazolidinedione et d'aryloxazolidinedione
ITPI20060083A1 (it) * 2006-07-11 2008-01-12 Univ Pisa Derivati 2,2-dimetilcromanici 4-spiro-eterocicilici azotati (a 5 e 6 termini) n-sostituiti quali cardio-protettori nei confronti dell'insulto ischemico
USD775790S1 (en) * 2015-11-18 2017-01-10 Ginger Damon Motorcycle jacket
RU2020123382A (ru) 2017-12-21 2022-01-21 Эссити Хайджин Энд Хелт Актиеболаг Впитывающее изделие и способ изготовления впитывающего изделия
RU2748513C1 (ru) 2017-12-21 2021-05-26 Эссити Хайджин Энд Хелт Актиеболаг Впитывающее изделие и способ изготовления впитывающего изделия

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1204232B (de) * 1959-07-16 1965-11-04 Ncr Co Verfahren zur Herstellung von Derivaten von 3-Alkyl-3'-methyl-spiro[benzoxazolin-2, 2'-(2'H-1'-benzopyran)]
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
CA1088945A (fr) * 1976-10-18 1980-11-04 Pfizer Limited Derives de l'hydantoine utilises comme agents therapeutiques

Also Published As

Publication number Publication date
FR2442851B1 (fr) 1983-06-17
IN152416B (fr) 1984-01-07
SE447116B (sv) 1986-10-27
AR225614A1 (es) 1982-04-15
GR71913B (fr) 1983-08-16
JPS5946517B2 (ja) 1984-11-13
JPS55129288A (en) 1980-10-06
DD146602A5 (de) 1981-02-18
JPS6011914B2 (ja) 1985-03-28
JPS55129280A (en) 1980-10-06
CS208129B2 (en) 1981-08-31
CH639974A5 (fr) 1983-12-15
FR2440949A1 (fr) 1980-06-06
GB2028318B (en) 1982-08-04
FR2440950B1 (fr) 1981-06-12
AU535170B2 (en) 1984-03-08
SE7906949L (sv) 1980-02-22
FR2442851A1 (fr) 1980-06-27
YU41488B (en) 1987-08-31
IE791592L (en) 1980-02-21
JPS5943954B2 (ja) 1984-10-25
PH18091A (en) 1985-03-20
NZ191350A (en) 1984-04-27
NL7906318A (nl) 1980-02-25
BE878311A (fr) 1980-02-20
JPS55129279A (en) 1980-10-06
SU942597A3 (ru) 1982-07-07
GB2033904B (en) 1982-08-04
PT70086A (en) 1979-09-01
ATA560579A (de) 1981-09-15
LU81613A1 (fr) 1980-04-21
US4200642A (en) 1980-04-29
FI65255C (fi) 1984-04-10
ES483511A1 (es) 1980-09-01
IL58076A0 (en) 1979-12-30
EG14639A (en) 1985-03-31
PL217881A1 (fr) 1981-01-02
GB2028318A (en) 1980-03-05
JPS5528996A (en) 1980-02-29
PL130686B1 (en) 1984-08-31
YU199979A (en) 1983-06-30
FR2440949B1 (fr) 1981-06-12
ZA794379B (en) 1980-08-27
AU5009279A (en) 1980-02-28
DE2933441A1 (de) 1980-02-28
FI65255B (fi) 1983-12-30
CA1121361A (fr) 1982-04-06
DE2933441C2 (fr) 1987-04-23
IT7925182A0 (it) 1979-08-20
JPS6011915B2 (ja) 1985-03-28
FI792567A (fi) 1980-02-22
HU179746B (en) 1982-12-28
GB2033904A (en) 1980-05-29
IE48932B1 (en) 1985-06-26
NO792699L (no) 1980-02-22
IT1123536B (it) 1986-04-30
DE2953954A1 (fr) 1982-09-02
DE2953954C2 (fr) 1987-12-03
DK258479A (da) 1980-02-22
AT366689B (de) 1982-04-26
FR2440950A1 (fr) 1980-06-06

Similar Documents

Publication Publication Date Title
NZ189378A (en) 4-amino-5-alkylsulphonyl-ortho-anisamdes and pharmaceutical compositions
IL58076A (en) Spiro-oxazolidine diones and pharmaceutical compositions containing them
NZ190784A (en) Benzofuranyl-piperidines and pharmaceutical compositions
IL56992A0 (en) N-heterocyclyl-4-piperidinamines their preparation and pharmaceutical compositions containing them
NZ192476A (en) Substituted benzamides and pharmaceutical compositions containing them
NZ192400A (en) 5-methylisoxazole-4-carboxylic acid-4-trifluoromethyl-anilide and pharmaceutical compositions containing it
NZ189438A (en) Perhaloalkylvinylcyclopropanecarboxylates intermediates and pharmaceutical compositions
IL58123A0 (en) 4,5-diaryl-2-nitroimidazoles their preparation and pharmaceutical compositions containing them
NZ190299A (en) 1,2,4-trizole -3,5- diamines and pharmaceutical compositions
NZ190745A (en) Mercapto-substituted -2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutical compositions
NZ190966A (en) Prostanoid compounds and pharmaceutical compositions
IL56407A (en) 4-amino-3-sulfamoylpyridyl derivatives and pharmaceutical compositions containing them
GB2038818B (en) Dihydropolyprenyl alcohols and pharmaceutical compositions thereof
IL56908A0 (en) N-oxacyclic alcylpiperidyl-diaza compounds their manufactuure and pharmaceutical compositions containig them
IL58415A0 (en) Phenyl-quinolizidines their manufacture and pharmaceutical compositions containing them
IL57268A0 (en) Di-o-n-alkyl clycerol derivatives and pharmaceutical compositions containing them
IL60376A (en) 3-diphenylmethyleneazetidines and pharmaceutical compositions containing them
JPS5535089A (en) Penamm1*11dioxide and its composition
NZ190521A (en) Phenylamino-thiophenacetic acids and pharmaceutical compositions
NZ189881A (en) 4,5-diaryl-2-(substituted-thio)-pyrroles and pharmaceutical compositions
NZ189899A (en) Dilignols and dilignol-type compounds pharmaceutical compositions
IL57476A0 (en) Compounds of the muramy-peptide type and pharmaceutical compositions containing them
PH14758A (en) New antibiotics and pharmaceutical compositions containing them
IL59177A0 (en) Spiro-quinolylhydantoins and pharmaceutical compositions containing them
NZ189279A (en) Arylaminoimidazolines and pharmaceutical compositions